• DOXAZOSIN CHEMBL707 FDA Approved

    Alternate Names:

    Doxazosin
    Cardura
    2-[4-(2,3-DIHYDRO-1,4-BENZODIOXINE-2-CARBONYL)PIPERAZIN-1-YL]-6,7-DIMETHOXY-3,4-DIHYDROQUINAZOLIN-4-IMINE
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-[(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)CARBONYL]PIPERAZINE
    1-(4-(2-(3-ETHYL-4-METHYL-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDO)ETHYL)PHENYLSULFONYL)-3-((1R,4R)-4-METHYLCYCLOHEXYL)UREA
    [4-(4-AMINO-6,7-DIMETHOXY-QUINAZOLIN-2-YL)PIPERAZIN-1-YL]-(2,3-DIHYDRO-1,4-BENZODIOXIN-3-YL)METHANONE
    BRD-A13188892-066-13-2
    3B2-4662
    27824-EP2314587A1
    27824-EP2305648A1
    27824-EP2305254A1
    27824-EP2301936A1
    27824-EP2298767A1
    27824-EP2298742A1
    27824-EP2272841A1
    27824-EP2270011A1
    EN300-53055
    V1927
    FT-0630831
    UK 33,274
    CAS_74191-85-8
    HE385066
    DR002794
    BC201641
    AN-37179
    NCGC00018158-08
    NCGC00018158-05
    NCGC00018158-03
    NCGC00018158-02
    RACEMIC MIXTURE DOXAZOSIN|||UK 33274
    NC00685
    MCULE-6153348827
    CS-1831
    CCG-118218
    AKOS017343634
    DAP000381
    HY-B0098
    HMS3372L09
    HMS3259N21
    MOLPORT-001-684-491
    CTK7A0339
    BDBM86731
    MET028
    GTPL7170
    SCHEMBL34111
    PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-[(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)CARBONYL]-
    CID3157
    CARDURAREG
    METHANONE, [4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL](2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)-
    2-{4-[(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)CARBONYL]PIPERAZIN-1-YL}-6,7-DIMETHOXYQUINAZOLIN-4-AMINE
    2-[4-(2,3-DIHYDRO-1,4-BENZODIOXINE-2-CARBONYL)PIPERAZIN-1-YL]-6,7-DIMETHOXYQUINAZOLIN-4-AMINE
    2-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLCARBONYL)PIPERAZIN-1-YL]-6,7-BIS(METHYLOXY)QUINAZOLIN-4-AMINE
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-[4-(1,4-BENZODIOXAN-2-YL)CARPIPERAZIN-1-YL)]-6,7-DIMETHOXYQUINAZOLINE MESYLATE
    [4-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)PIPERAZIN-1-YL]-(2,3-DIHYDRO-1,4-BENZODIOXIN-3-YL)METHANONE
    I06-1346
    BRD-A13188892-066-03-3
    PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-((2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)CARBONYL)-
    L000738
    D07874
    C06970
    LS-110228
    UK-33274
    SAM002589981
    CPD000097306
    AC-11062
    NCGC00089775-02
    NCGC00018158-06
    IDI1_003732
    DB00590
    1-(4-AMINO-6,7-DIMETHOXY-2-CHINAZOLINYL)-4-(2,3-DIHYDRO-1,4-BENZODIOXIXIN-2-YLCARBONYL)PIPERAZIN
    AKOS001681453
    2-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLCARBONYL)PIPERAZIN-1-YL]-6,7-DIMETHOXYQUINAZOLIN-4-AMINE
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(1,4-BENZODIOXAN-2-YLCARBONYL)PIPERAZIN
    HMS2090C20
    HMS1383E01
    RUZYUOTYCVRMRZ-UHFFFAOYSA-N
    77883-43-3 (MESYLATE)
    BPBIO1_000963
    AC1Q470P
    UNII-NW1291F1W8
    SPBIO_002796
    D9815_SIGMA
    UK 33274
    BSPBIO_000875
    OPREA1_259518
    LOPAC0_000474
    CHEMDIV2_005017
    PRESTWICK3_000858
    PRESTWICK2_000858
    PRESTWICK1_000858
    PRESTWICK0_000858
    AC1Q4EXN
    AC1L1FAT
    C23H25N5O5
    CHEBI:4708
    CARDURA XL (TN)
    SUPRESSIN
    DIBLOCIN
    ALFADIL
    DOXAZOSIN (INN)
    DOXAZOSIN [INN:BAN]
    DOXAZOSINA [SPANISH]
    DOXAZOSINUM [LATIN]
    DOXAZOSINE [FRENCH]
    CARDURA-4
    CARDURA-2
    CARDURA-1
    NORMOTHEN
    DOXAZOSINE
    DOXAZOSINA
    DOXAZOSINUM
    74191-85-8
    3157
    9184
    178103745
    7170

    Drug Info:

    FDA Approval 1990
    Drug Class small molecule
    Drug Indications Vasodilator Agents
    Drug Indications Antihypertensive Agents
    Drug Indications Anticholesteremic Agents
    Year of Approval 1990
    Drug Class anticholesteremic agents
    Drug Class antihypertensive agents
    Drug Class vasodilator agents
    (1 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Trial Name -
    Novel drug target Established target
    Specific Action of the Ligand Antagonist

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    DOXAZOSIN Primary Drug Name

    Drug Info:
    Drug Class anticholesteremic agents
    Year of Approval 1990
    Drug Class antihypertensive agents

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Anticholesteremic Agents
    Drug Indications Antihypertensive Agents
    Drug Indications Vasodilator Agents

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    DOXAZOSIN pubchem_primary_name
    3157 PubChem CID
    CARDURA Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    DOXAZOSIN GuideToPharmacology Ligand Name
    178103745 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    L000738 Drug Synonym
    CARDURA-4 Drug Synonym
    CPD000097306 Drug Synonym

    Drug Info:

    Publications: